Understanding climate change effects on end stage kidney disease patients

Climate change is driving more extreme heat and more air pollution from wildfires, each of which put human health at risk.

Comparative genomic analysis between systemic juvenile rheumatoid arthritis and type 1 diabetes

Shared genetic markers and immune system involvement in sJRA and T1D.

September 15, 2023

Bivalent COVID-19 vaccine boosts immunity but needs to be updated

A major bivalent COVID-19 vaccine induces production of neutralizing antibodies against the coronavirus that circulated at the start of the pandemic as well as subvariants

April 25, 2024

Pharmacosmos ventures into oncology and merges with G1 Therapeutics – Pharmaceutical Technology

The deal is centred around G1’s lead cyclin-dependent kinase 4/6 (CDK4/6) inhibitor Cosela (trilaciclib), which generated $46.3m in sales last year. Image Credit: Golden Sikorka

August 8, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.